Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation Reply

被引：0
作者：
Torn, Marieke [1 ]
Rosendaal, Frits R. [1 ]
机构：
[1] Leiden Univ, Dept Clin Epidemiol, Med Ctr, NL-2300 RC Leiden, Netherlands
来源：
ARCHIVES OF INTERNAL MEDICINE | 2009年 / 169卷 / 21期
关键词：
MYOCARDIAL-INFARCTION;
D O I：
10.1001/archinternmed.2009.421
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2033 / 2033
页数：1
相关论文
共 3 条
  • [1] OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES
    CANNEGIETER, SC
    ROSENDAAL, FR
    WINTZEN, AR
    VANDERMEER, FJM
    VANDENBROUCKE, JP
    BRIET, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) : 11 - 17
  • [2] Warfarin, aspirin, or both after myocardial infarction.
    Hurlen, M
    Abdelnoor, M
    Smith, P
    Erikssen, J
    Arnesen, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 969 - 974
  • [3] Optimal Level of Oral Anticoagulant Therapy for the Prevention of Arterial Thrombosis in Patients With Mechanical Heart Valve Prostheses, Atrial Fibrillation, or Myocardial Infarction A Prospective Study of 4202 Patients
    Torn, Marieke
    Cannegieter, Suzanne C.
    Bollen, Ward L. E. M.
    van der Meer, Felixj. M.
    van der Wall, Ernst E.
    Rosendaal, Frits R.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (13) : 1203 - 1209
1